Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 166 | 170 | PF00656 | 0.496 |
CLV_NRD_NRD_1 | 173 | 175 | PF00675 | 0.388 |
CLV_NRD_NRD_1 | 209 | 211 | PF00675 | 0.449 |
CLV_NRD_NRD_1 | 27 | 29 | PF00675 | 0.599 |
CLV_NRD_NRD_1 | 96 | 98 | PF00675 | 0.506 |
CLV_PCSK_KEX2_1 | 173 | 175 | PF00082 | 0.388 |
CLV_PCSK_KEX2_1 | 26 | 28 | PF00082 | 0.585 |
CLV_PCSK_KEX2_1 | 96 | 98 | PF00082 | 0.505 |
CLV_PCSK_SKI1_1 | 174 | 178 | PF00082 | 0.524 |
CLV_PCSK_SKI1_1 | 220 | 224 | PF00082 | 0.477 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.708 |
DEG_SCF_FBW7_2 | 222 | 229 | PF00400 | 0.486 |
DOC_CDC14_PxL_1 | 231 | 239 | PF14671 | 0.442 |
DOC_CKS1_1 | 123 | 128 | PF01111 | 0.446 |
DOC_CKS1_1 | 223 | 228 | PF01111 | 0.487 |
DOC_MAPK_MEF2A_6 | 238 | 246 | PF00069 | 0.520 |
DOC_PP1_SILK_1 | 220 | 225 | PF00149 | 0.480 |
DOC_USP7_MATH_1 | 209 | 213 | PF00917 | 0.503 |
DOC_USP7_MATH_1 | 247 | 251 | PF00917 | 0.537 |
DOC_WW_Pin1_4 | 107 | 112 | PF00397 | 0.504 |
DOC_WW_Pin1_4 | 122 | 127 | PF00397 | 0.443 |
DOC_WW_Pin1_4 | 222 | 227 | PF00397 | 0.484 |
DOC_WW_Pin1_4 | 39 | 44 | PF00397 | 0.498 |
LIG_14-3-3_CanoR_1 | 210 | 214 | PF00244 | 0.565 |
LIG_14-3-3_CanoR_1 | 3 | 9 | PF00244 | 0.740 |
LIG_14-3-3_CanoR_1 | 81 | 89 | PF00244 | 0.440 |
LIG_14-3-3_CanoR_1 | 96 | 100 | PF00244 | 0.433 |
LIG_Actin_WH2_2 | 151 | 167 | PF00022 | 0.432 |
LIG_BRCT_BRCA1_1 | 254 | 258 | PF00533 | 0.469 |
LIG_FHA_1 | 2 | 8 | PF00498 | 0.692 |
LIG_FHA_1 | 257 | 263 | PF00498 | 0.368 |
LIG_FHA_2 | 164 | 170 | PF00498 | 0.574 |
LIG_LIR_Apic_2 | 132 | 136 | PF02991 | 0.415 |
LIG_LIR_Apic_2 | 229 | 235 | PF02991 | 0.450 |
LIG_LIR_Gen_1 | 114 | 123 | PF02991 | 0.542 |
LIG_LIR_Gen_1 | 255 | 266 | PF02991 | 0.530 |
LIG_LIR_Nem_3 | 110 | 116 | PF02991 | 0.501 |
LIG_LIR_Nem_3 | 229 | 234 | PF02991 | 0.458 |
LIG_PDZ_Class_2 | 279 | 284 | PF00595 | 0.492 |
LIG_SH2_CRK | 133 | 137 | PF00017 | 0.398 |
LIG_SH2_CRK | 232 | 236 | PF00017 | 0.456 |
LIG_SH2_GRB2like | 16 | 19 | PF00017 | 0.574 |
LIG_SH2_NCK_1 | 116 | 120 | PF00017 | 0.411 |
LIG_SH2_NCK_1 | 123 | 127 | PF00017 | 0.379 |
LIG_SH2_NCK_1 | 133 | 137 | PF00017 | 0.351 |
LIG_SH2_SRC | 116 | 119 | PF00017 | 0.409 |
LIG_SH2_STAT3 | 213 | 216 | PF00017 | 0.306 |
LIG_SH2_STAT5 | 133 | 136 | PF00017 | 0.390 |
LIG_SH2_STAT5 | 141 | 144 | PF00017 | 0.346 |
LIG_SH2_STAT5 | 154 | 157 | PF00017 | 0.393 |
LIG_SH2_STAT5 | 178 | 181 | PF00017 | 0.535 |
LIG_SH2_STAT5 | 32 | 35 | PF00017 | 0.638 |
LIG_SH3_2 | 240 | 245 | PF14604 | 0.327 |
LIG_SH3_3 | 237 | 243 | PF00018 | 0.451 |
LIG_SH3_3 | 37 | 43 | PF00018 | 0.582 |
LIG_SH3_5 | 111 | 115 | PF00018 | 0.472 |
LIG_TRAF2_2 | 269 | 274 | PF00917 | 0.553 |
MOD_CK1_1 | 100 | 106 | PF00069 | 0.555 |
MOD_CK1_1 | 163 | 169 | PF00069 | 0.277 |
MOD_CK1_1 | 8 | 14 | PF00069 | 0.616 |
MOD_CK2_1 | 150 | 156 | PF00069 | 0.480 |
MOD_CK2_1 | 169 | 175 | PF00069 | 0.507 |
MOD_CK2_1 | 57 | 63 | PF00069 | 0.547 |
MOD_CMANNOS | 79 | 82 | PF00535 | 0.449 |
MOD_GlcNHglycan | 182 | 185 | PF01048 | 0.494 |
MOD_GlcNHglycan | 249 | 252 | PF01048 | 0.504 |
MOD_GlcNHglycan | 254 | 257 | PF01048 | 0.462 |
MOD_GlcNHglycan | 59 | 62 | PF01048 | 0.520 |
MOD_GlcNHglycan | 99 | 102 | PF01048 | 0.547 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.662 |
MOD_GSK3_1 | 159 | 166 | PF00069 | 0.475 |
MOD_GSK3_1 | 176 | 183 | PF00069 | 0.414 |
MOD_GSK3_1 | 252 | 259 | PF00069 | 0.526 |
MOD_GSK3_1 | 95 | 102 | PF00069 | 0.538 |
MOD_LATS_1 | 236 | 242 | PF00433 | 0.513 |
MOD_N-GLC_1 | 107 | 112 | PF02516 | 0.383 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.670 |
MOD_NEK2_1 | 131 | 136 | PF00069 | 0.484 |
MOD_PIKK_1 | 256 | 262 | PF00454 | 0.563 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.659 |
MOD_PKA_2 | 209 | 215 | PF00069 | 0.570 |
MOD_PKA_2 | 80 | 86 | PF00069 | 0.437 |
MOD_PKA_2 | 95 | 101 | PF00069 | 0.430 |
MOD_Plk_2-3 | 150 | 156 | PF00069 | 0.453 |
MOD_Plk_4 | 150 | 156 | PF00069 | 0.500 |
MOD_Plk_4 | 176 | 182 | PF00069 | 0.507 |
MOD_ProDKin_1 | 107 | 113 | PF00069 | 0.504 |
MOD_ProDKin_1 | 122 | 128 | PF00069 | 0.448 |
MOD_ProDKin_1 | 222 | 228 | PF00069 | 0.485 |
MOD_ProDKin_1 | 39 | 45 | PF00069 | 0.487 |
TRG_ENDOCYTIC_2 | 116 | 119 | PF00928 | 0.409 |
TRG_ENDOCYTIC_2 | 231 | 234 | PF00928 | 0.444 |
TRG_ER_diArg_1 | 26 | 28 | PF00400 | 0.585 |
TRG_ER_diArg_1 | 68 | 71 | PF00400 | 0.449 |
TRG_NLS_MonoExtN_4 | 26 | 32 | PF00514 | 0.685 |
TRG_Pf-PMV_PEXEL_1 | 165 | 169 | PF00026 | 0.444 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P338 | Leptomonas seymouri | 77% | 100% |
A0A1X0NU54 | Trypanosomatidae | 61% | 100% |
A0A3S7X5S2 | Leishmania donovani | 96% | 100% |
A0A422MUA3 | Trypanosoma rangeli | 56% | 100% |
A4HKL9 | Leishmania braziliensis | 85% | 100% |
A4I851 | Leishmania infantum | 96% | 100% |
D0AAB7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 58% | 100% |
D0AAB9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 57% | 73% |
Q4Q547 | Leishmania major | 96% | 100% |
V5BKN6 | Trypanosoma cruzi | 57% | 100% |